A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
Springboks Announce 12 Key Changes for Australia Clash in Rugby Championship
Top Family-Friendly Shows & Movies: 'Rick and Morty: The Anime,' 'Kaos' & More
Chelsea Seals Deal with Tosin Adarabioyo: Fulham Defender Joins on Four-Year Contract
Stream UEFA Nations League: Watch Hungary vs. Netherlands Live Anywhere
Dire Warning: Kenyan Shilling Could Plunge to Ksh170 Per US Dollar, Says Moses Kuria
